Skip to content
Catalyst

N(5)-ethyl-L-glutamineFinding

N(5)-ethyl-L-glutamine decreases Yale-Brown Obsessive Compulsive Scale (Y-BOCS) total score

lowersVery limited evidenceFinding

01 · The sentence it was drawn from

“Also, total Y-BOCS scores were lower in L-theanine compared to placebo group at week 5 (P = 0.039, Cohen's d = 0.60) and 10 (P = 0.008, Cohen's d = 0.80).”
Quoted verbatim from L-theanine combination therapy with fluvoxamine in moderate-to-severe obsessive-compulsive disorder: A placebo-controlled, double-blind, randomized trial.
This finding among the 1 finding on its endpoint

N(5)-ethyl-L-glutamine

Yale-Brown Obsessive Compulsive Scale (Y-BOCS) total score

lowers

Who
Adults 18-60 with DSM-5 OCD and baseline Y-BOCS above 21; fluvoxamine given to both arms as background (100 mg daily, 200 mg daily after week 5); 10-week parallel-group trial; primary outcome was Y-BOCS total decrease from baseline; result recorded is the week-10 contrast
Dose studied
L-theanine 100 mg twice daily, oral, added to fluvoxamine

Very limited evidencePMID 37169515 · 2023

02 · The study

Study
RCT
Duration
2 months

Evidence, by strength

  • strong
  • moderate
  • limited
  • very limitedthis finding
  • insufficient

04 · To cite this finding

This address does not change

https://catalystproject.ai/e/01M7EQKG7WFPVXMHV198PT0MYD